- Home
- Publications
- Publication Search
- Publication Details
Title
The Treatment of Lung Involvement in Systemic Sclerosis
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 14, Issue 2, Pages 154
Publisher
MDPI AG
Online
2021-02-14
DOI
10.3390/ph14020154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
- (2021) Kristin B Highland et al. Lancet Respiratory Medicine
- Predictors of progression in systemic sclerosis patients with interstitial lung disease
- (2020) Oliver Distler et al. EUROPEAN RESPIRATORY JOURNAL
- Safety and effectiveness of abatacept in Systemic Sclerosis: the EUSTAR experience
- (2020) Ivan Castellví et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT
- (2020) Mariaelena Occhipinti et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
- (2020) James R Seibold et al. ANNALS OF THE RHEUMATIC DISEASES
- Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review.
- (2020) Cosimo Bruni et al. European Journal of Internal Medicine
- Monitoring the microcirculation in the diagnosis and follow‐up of systemic sclerosis patients: Focus on pulmonary and peripheral vascular manifestations
- (2020) Barbara Ruaro et al. MICROCIRCULATION
- Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study
- (2020) Corrado Campochiaro et al. RHEUMATOLOGY
- Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope
- (2020) Monique Hinchcliff et al. Current Rheumatology Reports
- Evolution of interstitial lung disease one year after hematopoietic stem cell transplantation or cyclophosphamide for systemic sclerosis
- (2020) Jacopo Ciaffi et al. ARTHRITIS CARE & RESEARCH
- Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Dinesh Khanna et al. Lancet Respiratory Medicine
- Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
- (2019) Muriel Elhai et al. ANNALS OF THE RHEUMATIC DISEASES
- Cyclophosphamide: similarities and differences in the treatment of SSc and SLE
- (2019) C Bruni et al. LUPUS
- Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
- (2019) Oliver Distler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study
- (2019) Barbara Ruaro et al. RHEUMATOLOGY INTERNATIONAL
- Abatacept in Early Diffuse Cutaneous Systemic Sclerosis – Results of a Phase 2 Investigator‐Initiated, Multicenter, Double‐Blind Randomized Placebo‐Controlled Trial
- (2019) Dinesh Khanna et al. Arthritis & Rheumatology
- Recent advances steer the future of systemic sclerosis toward precision medicine
- (2019) Gemma Lepri et al. CLINICAL RHEUMATOLOGY
- Corticosteroid-sparing benefit of intravenous immunoglobulin in systemic sclerosis-associated myopathy: A comparative study in 52 patients
- (2019) Benjamin Chaigne et al. AUTOIMMUNITY REVIEWS
- Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II)
- (2018) Suzanne Kafaja et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
- (2018) Keith M. Sullivan et al. NEW ENGLAND JOURNAL OF MEDICINE
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Screening High-Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists
- (2018) Elana J. Bernstein et al. Arthritis & Rheumatology
- Treatment algorithms for systemic sclerosis according to experts
- (2018) Andreu Fernández-Codina et al. Arthritis & Rheumatology
- Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?
- (2018) Cosimo Bruni et al. Frontiers in Immunology
- The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial
- (2017) Leona M Dowman et al. THORAX
- Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
- (2017) Nicole S. Goh et al. Arthritis & Rheumatology
- Update of EULAR recommendations for the treatment of systemic sclerosis
- (2016) Otylia Kowal-Bielecka et al. ANNALS OF THE RHEUMATIC DISEASES
- Use of biologics and other novel therapies for the treatment of systemic sclerosis
- (2016) Cosimo Bruni et al. Expert Review of Clinical Immunology
- An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
- (2016) D. Khanna et al. JOURNAL OF RHEUMATOLOGY
- Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
- (2016) Dinesh Khanna et al. LANCET
- Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
- (2016) Luca Richeldi et al. RESPIRATORY MEDICINE
- Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
- (2016) Donald P Tashkin et al. Lancet Respiratory Medicine
- Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
- (2015) Lutz Wollin et al. EUROPEAN RESPIRATORY JOURNAL
- Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis
- (2015) Silvia L. Bosello et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease
- (2015) Yossra A. Suliman et al. Arthritis & Rheumatology
- Survival of Adults With Systemic Sclerosis Following Lung Transplantation: A Nationwide Cohort Study
- (2015) Elana J. Bernstein et al. Arthritis & Rheumatology
- Safety and Effectiveness of Mycophenolate in Systemic Sclerosis. A Systematic Review
- (2015) Mohammed A. Omair et al. PLoS One
- Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
- (2014) Suzana Jordan et al. ANNALS OF THE RHEUMATIC DISEASES
- Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease
- (2014) Tiffany A. Winstone et al. CHEST
- Two-year experience with mycophenolate mofetil in patients with scleroderma lung disease: a case series
- (2014) Neslihan Yilmaz et al. International Journal of Rheumatic Diseases
- Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
- (2014) Jacob M. van Laar et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improvement in lung fibrosis using intravenous immunoglobulin in systemic sclerosis with myositis
- (2014) W Mauhin et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study
- (2013) Stylianos T. Panopoulos et al. LUNG
- Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study
- (2012) Muriel Elhai et al. ANNALS OF THE RHEUMATIC DISEASES
- Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis
- (2012) Tatiana Barskova et al. ANNALS OF THE RHEUMATIC DISEASES
- T cells in systemic sclerosis: a reappraisal
- (2012) S. O'Reilly et al. RHEUMATOLOGY
- Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
- (2011) Richard K Burt et al. LANCET
- Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab
- (2010) Wan-Hee Yoo RHEUMATOLOGY INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now